[1] |
Chen Hongjian, Zhang Suqing.
Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients
[J]. Journal of International Oncology, 2024, 51(6): 344-349.
|
[2] |
Wang Ying, Liu Nan, Guo Bing.
Advances of antibody-drug conjugate in the therapy of metastatic breast cancer
[J]. Journal of International Oncology, 2024, 51(6): 364-369.
|
[3] |
Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.
Progress of radiotherapy in oligometastatic non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(3): 170-174.
|
[4] |
Peng Qin, Cai Yuting, Wang Wei.
Advances on KPNA2 in liver cancer
[J]. Journal of International Oncology, 2024, 51(3): 181-185.
|
[5] |
Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.
Research progress on the histopathological growth patterns of colorectal liver metastasis
[J]. Journal of International Oncology, 2024, 51(2): 114-118.
|
[6] |
Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.
Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells
[J]. Journal of International Oncology, 2023, 50(9): 513-519.
|
[7] |
Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.
Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer
[J]. Journal of International Oncology, 2023, 50(8): 475-483.
|
[8] |
Yang Lirong, Wang Yufeng.
Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer
[J]. Journal of International Oncology, 2023, 50(4): 220-226.
|
[9] |
Li Jiaxuan, Feng Yinglu.
Mechanism of action of glucocorticoid receptors in the growth of hepatoma cells
[J]. Journal of International Oncology, 2023, 50(4): 241-243.
|
[10] |
Ma Peihan, Zhang Lingming, Lu Ning, Zhang Mingxin.
Effect of anesthesia on the recurrence and metastasis of hepatocellular carcinoma
[J]. Journal of International Oncology, 2023, 50(2): 117-121.
|
[11] |
Zhao Jianhao, Duan Yanchao.
Research progress in the pathogenesis of extramedullary disease in multiple myeloma
[J]. Journal of International Oncology, 2023, 50(1): 55-59.
|
[12] |
Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou.
Advances in immunotherapy for recurrent and metastatic cervical cancer
[J]. Journal of International Oncology, 2022, 49(9): 517-520.
|
[13] |
He Ting, Wang Xi, Zhang Huizhong, Liu Xinyang, Wang Huiping, Dong Ke.
Diagnostic value of serum TIM-3 in patients with liver cancer
[J]. Journal of International Oncology, 2022, 49(9): 537-542.
|
[14] |
Peng Chen, Xie Yintong, Zhang Xin, Xie Peng.
Research progress of maintenance therapy for cervical cancer
[J]. Journal of International Oncology, 2022, 49(7): 430-435.
|
[15] |
Zhang Yumin, Zhao Xianwei, He Qianjin, Chen Jieneng.
Value of contrast-enhanced ultrasound combined with serum CXCL8 and CXCR2 in the evaluation of postoperative efficacy of transcatheter arterial chemoembolization for primary liver cancer
[J]. Journal of International Oncology, 2022, 49(10): 592-596.
|